Home Other Building Blocks 1,8,9-anthracenetriol

1,8,9-anthracenetriol

CAS No.:
480-22-8
Catalog Number:
AG003767
Molecular Formula:
C14H10O3
Molecular Weight:
226.2274
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003767
Chemical Name:
1,8,9-anthracenetriol
CAS Number:
480-22-8
Molecular Formula:
C14H10O3
Molecular Weight:
226.2274
MDL Number:
MFCD00001250
IUPAC Name:
anthracene-1,8,9-triol
InChI:
InChI=1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-7,15-17H
InChI Key:
YUTJCNNFTOIOGT-UHFFFAOYSA-N
SMILES:
Oc1cccc2c1c(O)c1c(c2)cccc1O
NSC Number:
403736
Properties
Complexity:
255  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
226.063g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
226.231g/mol
Monoisotopic Mass:
226.063g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
60.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.9  
Literature
Title Journal
Anthralin/dithranol in dermatology. International journal of dermatology 20141001
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. Chemico-biological interactions 20130905
Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chemical research in toxicology 20130617
Dithranol as a MALDI matrix for tissue imaging of lipids by Fourier transform ion cyclotron resonance mass spectrometry. Analytical chemistry 20121002
Dithranol downregulates expression of Id1 mRNA in human keratinocytes in vitro. Genetics and molecular research : GMR 20120913
Dithranol: an unusual agent to produce artificial (false) bruise: a case report. The American journal of forensic medicine and pathology 20120901
Effect of anthralin on cell viability in human prostate adenocarcinoma. Bulletin of experimental biology and medicine 20120701
Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 20120501
[Children and adolescents with psoriasis. What therapy is recommended?]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120301
Sublimation of new matrix candidates for high spatial resolution imaging mass spectrometry of lipids: enhanced information in both positive and negative polarities after 1,5-diaminonapthalene deposition. Analytical chemistry 20120221
Effects of the antipsoriatic drug dithranol on E2A and caspase-9 gene expression in vitro. Genetics and molecular research : GMR 20120217
Targeted 307 nm UVB-excimer light vs. topical dithranol in psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 20120101
Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20120101
Inflammatory linear verrucous epidermal nevus syndrome with its polymorphic presentation - A rare case report. Contemporary clinical dentistry 20120101
Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl-dithranol, on HaCaT cells. Molecular pharmaceutics 20111205
[Treatment of disseminated granuloma annulare with anthralin]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20111201
The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer metastasis reviews 20111201
Therapy of psoriasis in childhood and adolescence - a German expert consensus. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20111001
Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. The Journal of investigative dermatology 20110901
A selective optical sensor for beryllium determination based on incorporating of 1,8-dihydroxyanthrone in a poly (vinyl chloride) membrane. Journal of hazardous materials 20110615
Keratinocyte secretion of cyclophilin B via the constitutive pathway is regulated through its cyclosporin-binding site. The Journal of investigative dermatology 20110501
308-nm Excimer laser treatment of palmoplantar psoriasis. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20110401
Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. Journal of microencapsulation 20110101
Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study. Indian journal of dermatology 20110101
Drug nanoparticle formulation using ascorbic Acid derivatives. Journal of drug delivery 20110101
Comparative therapeutic evaluation of different topicals and narrow band ultraviolet B therapy combined with systemic methotrexate in the treatment of palmoplantar psoriasis. Indian journal of dermatology 20110101
Vitiligo: a review of some facts lesser known about depigmentation. Indian journal of dermatology 20110101
Alopecia areata - probing the deforestation. International journal of trichology 20110101
Psoriasis in children: an insight. Indian journal of dermatology 20110101
Estimation of the postmortem duration of mouse tissue by electron spin resonance spectroscopy. Journal of toxicology 20110101
Alopecia areata: a new treatment plan. Clinical, cosmetic and investigational dermatology 20110101
Utility of dermoscopy in alopecia areata. Indian journal of dermatology 20110101
Extensive alopecia areata: not necessarily recalcitrant to therapy! International journal of trichology 20110101
Eosinophilia during psoriasis treatment with TNF antagonists. Dermatology (Basel, Switzerland) 20110101
Molecular and physiological mechanisms of membrane receptor systems functioning. Acta naturae 20110101
Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining. Pharmaceutical research 20101201
Synthesis and biological evaluation of novel 10-benzyl-substituted 4,5-dichloro-10H-anthracen-9-ones as inhibitors of keratinocyte hyperproliferation. European journal of medicinal chemistry 20101101
Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth. European journal of medicinal chemistry 20101101
Antibacterial activity of Alpinia galanga (L) Willd crude extracts. Applied biochemistry and biotechnology 20101001
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis 20100901
Structure-activity relationship studies of acridones as potential antipsoriatic agents. 1. Synthesis and antiproliferative activity of simple N-unsubstituted 10H-acridin-9-ones against human keratinocyte growth. European journal of medicinal chemistry 20100801
Isolation, purification, and study of properties of recombinant hepsin from Escherichia coli. Biochemistry. Biokhimiia 20100701
Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. Journal of the American Academy of Dermatology 20100601
Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay. Assay and drug development technologies 20100601
Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression. Toxicology in vitro : an international journal published in association with BIBRA 20100401
An EPR method for estimating activity of antioxidants in mouse skin using an anthralin-derived radical model. Free radical research 20100301
Application of the improved BALB/c 3T3 cell transformation assay to the examination of the initiating and promoting activities of chemicals: the second interlaboratory collaborative study by the non-genotoxic carcinogen study group of Japan. Alternatives to laboratory animals : ATLA 20100301
Photothermal imaging in 3D surface analysis of membrane drug delivery. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100101
FTIR microscopy and confocal Raman microscopy for studying lateral drug diffusion from a semisolid formulation. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100101
Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion. Dermatology (Basel, Switzerland) 20100101
Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areata. Indian journal of dermatology 20100101
Bilateral treatment for alopecia areata. Pediatric dermatology 20100101
Management of alopecia areata. BMJ (Clinical research ed.) 20100101
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis. Core evidence 20100101
Lipid disturbances in psoriasis: an update. Mediators of inflammation 20100101
Redox imbalance in T cell-mediated skin diseases. Mediators of inflammation 20100101
Topical immunotherapy in alopecia areata. International journal of trichology 20100101
Cytotoxic terpene quinones from marine sponges. Marine drugs 20100101
Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy. Journal of the European Academy of Dermatology and Venereology : JEADV 20091201
Childhood psoriasis: often favorable outcome. Prescrire international 20091201
Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions. Clinical and experimental dermatology 20090701
Natural anthraquinone derivatives from a marine mangrove plant-derived endophytic fungus Eurotium rubrum: structural elucidation and DPPH radical scavenging activity. Journal of microbiology and biotechnology 20090701
Treatment of alopecia areata in children. Pediatric annals 20090701
[Topical treatments for psoriasis in 2009]. Revue medicale suisse 20090422
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. Journal of the American Academy of Dermatology 20090401
The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? Dermatology online journal 20090315
Therapeutic moisturizers as adjuvant therapy for psoriasis patients. American journal of clinical dermatology 20090101
Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons. BMC neuroscience 20090101
Practice of phototherapy in the treatment of moderate-to-severe psoriasis. Current problems in dermatology 20090101
Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature. Journal of medical case reports 20090101
Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study. BMC dermatology 20090101
Hydrophilic silica aerogels as dermal drug delivery systems--dithranol as a model drug. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080801
Psoriasis: characteristics, psychosocial effects and treatment options. British journal of nursing (Mark Allen Publishing) 20080301
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. The British journal of dermatology 20080201
Separation and preconcentration of ultra trace amounts of beryllium in water samples using mixed micelle-mediated extraction and determination by inductively coupled plasma-atomic emission spectrometry. Analytica chimica acta 20080128
Accentuated Blaschko-linear manifestation of psoriasis. European journal of dermatology : EJD 20080101
The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent. Molecular carcinogenesis 20071201
[Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it]. MMW Fortschritte der Medizin 20070906
[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20070901
Altered expression of prohibitin in psoriatic lesions and its cellular implication. Biochemical and biophysical research communications 20070831
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. Journal of the American Academy of Dermatology 20070701
Alopecia areata. International journal of dermatology 20070201
In search for new antipsoriatic agents: NAD topical composition. Skin pharmacology and physiology 20070101
A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. The Journal of dermatological treatment 20070101
Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin. Brain research 20061122
[The immunology of psoriasis: from basic research to the bedside]. Orvosi hetilap 20061119
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. The British journal of dermatology 20061001
Defensive components in insect eggs: are anthraquinones produced during egg development? Journal of chemical ecology 20060901
[Maintenance therapy of psoriasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20060801
[Classical topical therapy of psoriasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20060801
The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes. Experimental dermatology 20060801
[Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20060801
Potential use of ascorbic acid-based surfactants as skin penetration enhancers. Drug development and industrial pharmacy 20060801
Anthralin: primary products of its redox reactions. The Journal of organic chemistry 20060707
Cyclosporin A treatment in severe childhood psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 20060701
Chronic plaque psoriasis. Clinical evidence 20060601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Location of anthralin radical generation in mouse skin by UV-A irradiation: an estimation using microscopic EPR spectral-spatial imaging. Magnetic resonance in medicine 20060401
Alpha-glucosidase inhibitory anthranols, kenganthranols A-C, from the stem bark of Harungana madagascariensis. Journal of natural products 20060201
Characterization of various analytes using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and 2-[(2E)-3-(4-tert-butylphenyl)-2-methylprop-2-enylidene]malononitrile matrix. Analytical chemistry 20060101
Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators of inflammation 20060101
Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy. Acta dermatovenerologica Croatica : ADC 20060101
Treatment of childhood psoriasis. Acta dermatovenerologica Croatica : ADC 20060101
Fluorescent sensing of transition metal ions based on the encapsulation of dithranol in a polymeric core shell architecture. Chemical communications (Cambridge, England) 20050928
Inhibition of the nuclear factor-kappaB signaling pathway by leflunomide or triptolide also inhibits the anthralin-induced inflammatory response but does not affect keratinocyte growth inhibition. Biological & pharmaceutical bulletin 20050901
A clinician's paradigm in the treatment of psoriasis. Journal of the American Academy of Dermatology 20050701
Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1. Journal of the European Academy of Dermatology and Venereology : JEADV 20050701
The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050601
[Health economic aspects of psoriasis therapy. Is inpatient topical treatment of plaque-type psoriasis in this age of biologics still appropriate from both medical and economic viewpoints?]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20050601
Chronic plaque psoriasis. Clinical evidence 20050601
Analysis of poly(oxyethylene) and poly(oxypropylene) triblock copolymers by MALDI-TOF mass spectrometry. Analytical chemistry 20050515
Topical therapies for psoriasis: evidence-based review. Canadian family physician Medecin de famille canadien 20050410
Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. The Journal of dermatological treatment 20050401
Dithranol irritation in psoriasis treatment: a study of 68 inpatients. Journal of the European Academy of Dermatology and Venereology : JEADV 20050301
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation. BMC neuroscience 20050101
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC dermatology 20050101
The effect of treatment on quality of life in psoriasis patients. Acta dermato-venereologica 20050101
Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study. American journal of clinical dermatology 20050101
Linear naevoid psoriasis along lines of Blaschko. Journal of the European Academy of Dermatology and Venereology : JEADV 20041101
Physiological variation in the erythemal response to ultraviolet radiation and photoadaptation. The Journal of investigative dermatology 20041101
RNase P: a promising molecular target for the development of new drugs. Current medicinal chemistry 20041101
Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE(2) generation and proliferation in the HaCaT cell line. Journal of natural products 20040901
Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. The Journal of biological chemistry 20040702
Chronic plaque psoriasis. Clinical evidence 20040601
Interleukin 4 plasma levels in psoriasis vulgaris patients. Medical science monitor : international medical journal of experimental and clinical research 20040401
Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation. Experimental dermatology 20040201
[Comment on the letter and response regarding 'Treatment of psoriasis capilliti with Dethranol]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20040201
Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp. Skin pharmacology and physiology 20040101
Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Experimental dermatology 20040101
Treating psoriatic arthritis: how effective are TNF antagonists? Arthritis research & therapy 20040101
Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis. European journal of dermatology : EJD 20040101
Effect of matrix and solvent on the analysis of novel poly(phenylenevinylene) derivatives by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid communications in mass spectrometry : RCM 20040101
Historical development of local therapy of psoriasis vulgaris. Acta dermatovenerologica Croatica : ADC 20040101
Coagels from alkanoyl-6-O-ascorbic acid derivatives as drug carriers: structure and rheology. Farmaco (Societa chimica italiana : 1989) 20031201
Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial. The British journal of dermatology 20031201
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten,W. Sterry and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003, 1:688-693]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20031201
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten, W. Steary and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003; 1:688-693]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20031201
Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients. Nutrition (Burbank, Los Angeles County, Calif.) 20031001
Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. The journal of investigative dermatology. Symposium proceedings 20031001
Guidelines for the management of alopecia areata. The British journal of dermatology 20031001
Recalcitrant psoriasis vulgaris associated with Laurence-Moon-Biedl syndrome. Journal of the European Academy of Dermatology and Venereology : JEADV 20030901
[Dithranol in the treatment of scalp psoriasis]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20030901
Dithranol reaction with nitroxide radicals in DMSO, a HPLC study. Die Pharmazie 20030701
Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats. The journal of investigative dermatology. Symposium proceedings 20030601
Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. The British journal of dermatology 20030401
[Phototherapy and photochemotherapy of inflammatory dermatoses]. MMW Fortschritte der Medizin 20030220
A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatology online journal 20030201
The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis. Skin pharmacology and applied skin physiology 20030101
Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Skin pharmacology and applied skin physiology 20030101
The topical treatment of psoriasis. Skin pharmacology and applied skin physiology 20030101
Models of acute inflammation in the ear. Methods in molecular biology (Clifton, N.J.) 20030101
Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation. European journal of dermatology : EJD 20030101
Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In vitro cellular & developmental biology. Animal 20030101
Connubial contact dermatitis: an unusual pregnancy dermatosis. Acta dermato-venereologica 20030101
Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20030101
Calcipotriol cream in the treatment of flexural psoriasis. International journal of tissue reactions 20030101
Chronic plaque psoriasis. Clinical evidence 20021201
[Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20021201
Twice-daily vs. once-daily inpatient dithranol for psoriasis. Clinical and experimental dermatology 20021101
Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment. The British journal of dermatology 20020901
Fabric-staining properties and washability of a novel liposomal dithranol formulation. The Journal of dermatological treatment 20020901
A novelliposomal formulation of dithranol for psoriasis: preliminary results. The Journal of dermatology 20020801
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. The Journal of investigative dermatology 20020701
Chronic plaque psoriasis. Clinical evidence 20020601
Low-dose dithranol treatment and tape stripping induce tolerance to dithranol in a mouse ear oedema model. The British journal of dermatology 20020501
[Alopecia areata: update on therapy]. Annales de dermatologie et de venereologie 20020501
Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. The British journal of dermatology 20020401
Topical agents for the treatment of psoriasis, past, present and future. Journal of cutaneous medicine and surgery 20020101
Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies. Journal of cutaneous medicine and surgery 20020101
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. Dermatology (Basel, Switzerland) 20020101
Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. Skin pharmacology and applied skin physiology 20020101
A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes. Skin pharmacology and applied skin physiology 20020101
The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment. Skin pharmacology and applied skin physiology 20020101
Psoriasis and pregnancy. Journal of cutaneous medicine and surgery 20020101
The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment. Skin pharmacology and applied skin physiology 20020101
An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream. Skin pharmacology and applied skin physiology 20020101
The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs. Skin pharmacology and applied skin physiology 20020101
Managing the patient with psoriasis. The Practitioner 20011101
Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types. The British journal of dermatology 20011101
Management of psoriasis. Australian family physician 20011101
Self-sensitized photooxygenation of 3,4-dialkoxyfurans to vitamin C or its derivatives. The Journal of organic chemistry 20011019
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. International journal of pharmaceutics 20011009
Treatment of psoriasis. Part 1. Topical therapy and phototherapy. Journal of the American Academy of Dermatology 20011001
Evidence-based treatment of alopecia areata. Journal of the American Academy of Dermatology 20011001
[Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20010801
An unusual case of melanosis coli. Gastrointestinal endoscopy 20010701
The influence of a topical corticosteroid on short-contact high-dose dithranol therapy. The British journal of dermatology 20010701
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study. Acta dermato-venereologica 20010501
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis. The British journal of dermatology 20010401
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones. Journal of medicinal chemistry 20010301
Cornified envelope formation by anthralin, simple analogues, and related anthracenones. Archiv der Pharmazie 20010301
[Alopecia areata: management strategy]. Annales de dermatologie et de venereologie 20010201
10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis. European journal of medicinal chemistry 20010201
Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation. Bioorganic & medicinal chemistry letters 20010108
Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20010101
Reduced levels of glutathione S-transferases in patch test reactions to dithranol and sodium lauryl sulphate as demonstrated by quantitative immunocytochemistry: evidence for oxidative stress in acute irritant contact dermatitis. European journal of dermatology : EJD 20010101
Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. Dermatology (Basel, Switzerland) 20010101
The impact of the frequency of short contact dithranol treatment. European journal of dermatology : EJD 20010101
Dithranol and dimethylfumarate suppress the interferon-gamma-induced up-regulation of cytokeratin 17 as a putative psoriasis autoantigen in vitro. Skin pharmacology and applied skin physiology 20010101
New aspects in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a universal solvent-free sample preparation. Rapid communications in mass spectrometry : RCM 20010101
[Psoriasis]. Acta medica portuguesa 20010101
Psoriasis in children: a guide to its diagnosis and management. Paediatric drugs 20010101
Psoriasis of the scalp. Diagnosis and management. American journal of clinical dermatology 20010101
Activity of Tumor Necrosis Factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20010101
Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 19980401
Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Molecular carcinogenesis 19961201
Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 alpha mRNA and protein expression in SENCAR mice by green tea polyphenols. The Journal of investigative dermatology 19950901
Altered expression of transforming growth factor-beta 1 mRNA and protein in mouse skin carcinogenesis. Molecular carcinogenesis 19940401
Modulation of interleukin-1 alpha mRNA expression in mouse epidermis by tumor promoters and antagonists. Molecular carcinogenesis 19930101
Anthralin: historical and current perspectives. Journal of the American Academy of Dermatology 19830801
Properties